Mild liver injury following withdrawal of long-term prednisone therapy: A case report.

IF 5.4 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY World Journal of Gastroenterology Pub Date : 2025-01-28 DOI:10.3748/wjg.v31.i4.102135
Jing-Wen Zhu, Jun Yan, Zhi-Han Zhang, Tian-Qi Wang
{"title":"Mild liver injury following withdrawal of long-term prednisone therapy: A case report.","authors":"Jing-Wen Zhu, Jun Yan, Zhi-Han Zhang, Tian-Qi Wang","doi":"10.3748/wjg.v31.i4.102135","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Liver injury manifesting as hepatic enzyme abnormalities, has been occasionally identified to be a feature of primary or secondary Addison's disease, an uncommon endocrine disease characterized by adrenal insufficiency. There have been no more than 30 reported cases of liver injury explicitly attributed to Addison's disease. Liver injury resulting from adrenal insufficiency due to glucocorticoid withdrawal is exceptionally rarer.</p><p><strong>Case summary: </strong>A 42-year-old man presented with fatigue and mildly elevated transaminases. Laboratory investigations and imaging studies excluded common etiologies of liver injury. Based on the fact that the patient discontinued long-term therapy with prednisone approximately 2 weeks before he was found to have elevated transaminase levels and the observation that his cortisol was lower than the normal value, he was diagnosed as having hypertransaminasemia secondary to adrenal insufficiency caused by glucocorticoid withdrawal. The patient was infused intravenously with compound diisopropylamine dichloroacctate and compound glycyrrhizin, and his transaminase levels returned to normal after 1 week. Approximately 2 years later, the patient received hydroprednisone treatment for 2 days in an endoscopic sinus surgery. Eight days after he discontinued the hydroprednisone treatment, he developed symptoms reminiscent of glucocorticoid withdrawal syndrome. These symptoms resolved spontaneously after 1 week. Intriguingly, the patient did not develop hepatic dysfunction this time.</p><p><strong>Conclusion: </strong>The present case, showing some unusual clinical features, highlights the importance of education of clinicians and patients to avoid improper discontinuation of glucocorticoid therapy and complete history taking for prompt recognition.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"31 4","pages":"102135"},"PeriodicalIF":5.4000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718648/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v31.i4.102135","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Liver injury manifesting as hepatic enzyme abnormalities, has been occasionally identified to be a feature of primary or secondary Addison's disease, an uncommon endocrine disease characterized by adrenal insufficiency. There have been no more than 30 reported cases of liver injury explicitly attributed to Addison's disease. Liver injury resulting from adrenal insufficiency due to glucocorticoid withdrawal is exceptionally rarer.

Case summary: A 42-year-old man presented with fatigue and mildly elevated transaminases. Laboratory investigations and imaging studies excluded common etiologies of liver injury. Based on the fact that the patient discontinued long-term therapy with prednisone approximately 2 weeks before he was found to have elevated transaminase levels and the observation that his cortisol was lower than the normal value, he was diagnosed as having hypertransaminasemia secondary to adrenal insufficiency caused by glucocorticoid withdrawal. The patient was infused intravenously with compound diisopropylamine dichloroacctate and compound glycyrrhizin, and his transaminase levels returned to normal after 1 week. Approximately 2 years later, the patient received hydroprednisone treatment for 2 days in an endoscopic sinus surgery. Eight days after he discontinued the hydroprednisone treatment, he developed symptoms reminiscent of glucocorticoid withdrawal syndrome. These symptoms resolved spontaneously after 1 week. Intriguingly, the patient did not develop hepatic dysfunction this time.

Conclusion: The present case, showing some unusual clinical features, highlights the importance of education of clinicians and patients to avoid improper discontinuation of glucocorticoid therapy and complete history taking for prompt recognition.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长期强的松治疗停药后轻度肝损伤1例报告。
背景:肝损伤表现为肝酶异常,偶尔被认为是原发性或继发性Addison病(一种少见的以肾上腺功能不全为特征的内分泌疾病)的一个特征。明确归因于Addison病的肝损伤病例报道不超过30例。由于糖皮质激素停用引起的肾上腺功能不全引起的肝损伤是非常罕见的。病例总结:一名42岁男性,表现为疲劳和轻度转氨酶升高。实验室调查和影像学检查排除了肝损伤的常见病因。根据患者在发现转氨酶水平升高前约2周停用强的松长期治疗,并观察到其皮质醇低于正常值,诊断为糖皮质激素停药引起的继发于肾上腺功能不全的高转氨血症。患者静脉滴注复方二氯乙酸二异丙胺和复方甘草酸,1周后转氨酶恢复正常。大约2年后,患者在内窥镜鼻窦手术中接受了2天的氢泼尼松治疗。在他停止氢强的松治疗8天后,他出现了让人想起糖皮质激素戒断综合征的症状。这些症状在1周后自行消退。有趣的是,这次患者没有出现肝功能障碍。结论:本病例表现出一些不寻常的临床特征,强调了对临床医生和患者进行教育的重要性,以避免不当停用糖皮质激素治疗和完整的病史,以便及时识别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
期刊最新文献
Influence of blood transfusion on outcomes in patients with gastric cancer. Correction to "Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma". Distribution and prognostic value of macrophages in colorectal cancer and adjacent mucosa in patient stages I-III vs IV. Gut bacterial and fungal signatures in relation to human leukocyte antigen-DQ2/DQ8 in children with celiac disease and siblings. Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1